- Reviewed literature on polysubstance use and motor vehicle fatality risk in the U.S.- Conducted a study investigating the relationship between polysubstance use and motor vehicle fatality risk using the Fatality Analysis Reporting System (FARS) database and used two specific aims to assess the association between motor vehicle fatality risk and trends in polysubstance impairment during the study period (2018-2022): 1) polysubstance impairment (BAC ≥ 0.08 and positive for one or more nonalcohol drug) and 2) polysubstance influence (BAC ≥ 0.05 and positive for one or more nonalcohol drug) - Presented findings including tables and figures in weekly meetings to update the analysis

- Mentored by Dr. Cecilia Uribe MD, Medical Director-CFHI La Paz, Bolivia- Reviewed literature on the state of COVID-19 vaccination efforts and vaccination rates for other communicable illnesses during the pandemic- Prepared a presentation on “Routine & COVID-19 vaccination distribution in Bolivia for the General Population 2021”- Presented research on the state of the current uptake of immunizations for communicable illnesses and COVID-19 among indigenous populations to participants in the CFHI program and Dr. Uribe- Participated in weekly lectures on various global health topics in Bolivia

- Prepared solid, and liquid nanoparticles for X-Ray Diffraction (XRD) and Differential Scanning Calorimetry (DSC) analysis - Used reverse-phase High-Pressure Liquid Chromatography (HPLC) to analyze the properties of a drug tested for clinical trials- Conducted dissolution testing with multiple time points under a variety of conditions- Conducted serial dilutions and solubility trials on APIs and proteins for stability studies